Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl

Bo-Kyung Son1, Koichi Kozaki, Katsuya Iijima

  • 1Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.

Circulation Research
|March 25, 2006
PubMed

Insights

Statins prevent vascular calcification by inhibiting apoptosis in human aortic smooth muscle cells. This effect is mediated by restoring the Gas6-Axl pathway, crucial for cell survival.

Area of Science:

  • Cardiovascular Biology
  • Cellular and Molecular Medicine
  • Pharmacology

Background:

  • Vascular calcification is a key factor in cardiovascular disease development.
  • Statins (HMG CoA reductase inhibitors) show potential in inhibiting vascular calcification, but mechanisms remain unclear.
  • Apoptosis is increasingly recognized as a regulator of vascular smooth muscle cell (VSMC) calcification.

Purpose of the Study:

  • To investigate the effect of statins on VSMC calcification.
  • To elucidate the role of apoptosis and the Gas6-Axl pathway in statin-mediated inhibition of vascular calcification.

Main Methods:

  • Used human aortic smooth muscle cells (HASMC) treated with inorganic phosphate (Pi) and statins.
  • Assessed calcification, apoptosis, sodium-dependent phosphate cotransporter (NPC) activity, and Gas6/Axl pathway expression.
  • Utilized small interfering RNA (siRNA) to suppress Gas6 and Axl function.

Main Results:

  • Statins significantly inhibited Pi-induced HASMC calcification in a dose-dependent manner.
  • Statin's inhibitory effect was linked to preventing Pi-induced apoptosis, not altering NPC activity.
  • Statins restored Gas6 expression, which was downregulated by Pi, via mRNA stabilization.
  • Suppression of Gas6 or Axl abolished the protective effects of statins.

Conclusions:

  • Statins protect HASMC from Pi-induced calcification by inhibiting apoptosis.
  • The mechanism involves the restoration of the Gas6-Axl survival pathway.
  • Targeting the Gas6-Axl pathway may offer therapeutic strategies for vascular calcification.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...